Celator Pharmaceuticals, Inc. is a biopharmaceutical company based in Palo Alto, California, focused on developing innovative therapies for cancer treatment. The company specializes in the formulation and delivery of drugs that enhance the efficacy and safety of existing therapies. Celator employs advanced technologies to optimize drug combinations and improve patient outcomes. Its research initiatives are centered on addressing unmet medical needs in oncology, aiming to provide more effective treatment options for patients battling cancer.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

25 Patents

#71 in Palo Alto, CA

#3,158 in California

#13,370 in US

#25,730 in the World

Palo Alto, CA, United States of America

Celator Pharmaceuticals, Inc.

Forward Citations = 601

34 inventors:

Lawrence D Mayer (17 out of 31 patents)

Paul Tardi (15 out of 17 patents)

Murray Webb (7 out of 7 patents)

4. Troy Harasym (6 out of 6 patents)

5. Andrew S Janoff (6 out of 80 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Celator Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/celator-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

11 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]